ערך בספרים למניה: 10x Genomics Inc (TXG)
The asset value of 10x Genomics, Inc. (TXG) tracked on this chart is currently at 6.31. Management effectively protects patents and minimizes the influence of majority shareholders through the capital structure. The company generates stable income from the sale of cell analysis equipment and ancillary reagents. The continuity of these processes is ensured by the modernization of automated facilities, where equipment operates at maximum efficiency.
TXG (10xgenomics.com): פילוחים אנליטיים ודוחות לפי אינדיקטורים
10x Genomics, Inc. (TXG) dominates the single-cell analysis equipment and spatial biology segment. The book value per share determines the portion of net assets available to the owner of a single security after all liabilities are settled. Investors utilize this metric to assess the actual capital density of the business. The BVPS trend allows for the tracking of financial stability between reports, which minimizes the risks of sudden capital impairment.